Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

(These articles have been accepted for this issue. Change is possible before publication.)


Receive this page by email each issue: [Sign up for eTOCs]

Future Table of Contents: May 20 2008; 26 (15)

      Down ORIGINAL REPORTS
      Down Thoracic Oncology
      Down Palliative Care
      Down Breast Cancer
      Down Head and Neck Cancer
      Down Genitourinary Cancer
      Down Hematologic Malignancies
      Down Gastrointestinal Cancer
      Down Supportive Care and Quality of Life
      Down AIDS-Related Cancer
      Down Gynecologic Cancer
      Down SPECIAL ARTICLE
      Down BIOLOGY OF NEOPLASIA

ORIGINAL REPORTSBack

Thoracic OncologyBack


First-Line Gefitinib in Advanced Non-Small-Cell Lung Cancer Patients Harboring Somatic EGFR Mutations
Lecia V. Sequist, Renato G. Martins, David Spigel, Steven M. Grunberg, Alexander Spira, Pasi A. Janne, Victoria A. Joshi, David McCollum, Tracey L. Evans, Alona Muzikansky, Georgiana L. Kuhlmann, Moonjoo Han, Jonathan S. Goldberg, Jeffrey Settleman, A. John Iafrate, Jeffrey Engelman, Daniel A. Haber, Bruce E. Johnson, and Thomas J. Lynch

Phase III Trial of Maintenance Gefitinib After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non-Small-Cell Lung Cancer: Southwest Oncology Group S0023
Karen Kelly, Kari Chansky, Laurie Gaspar, Kathy Albain, James Jett, Yee Ung, Derick Lau, John Crowley, and David Gandara

Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676 (CPG 7909), in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non-Small-Cell Lung Cancer
Christian Manegold, Donald Gravenor, Donald Woytowitz, Jorg Mezger, Vera Hirsh, Gary Albert, Mohammed Al-Adhami, David Readett, Arthur M. Krieg, and Gail Leichman

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non-Small-Cell Lung Cancer: CALGB 30105
Mark A. Socinski, A. William Blackstock, Jeffrey A. Bogart, Xiaofei Wang, Michael Munley, Julian Rosenman, Lin Gu, Gregory A. Masters, Peter Ungaro, Arthur Sleeper, Mark Green, Antonius A. Miller, and Everett E. Vokes

Palliative CareBack

Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography
Kathy P. Parker, Donald L. Bliwise, Maria J.A. Ribeiro, Sanjay R. Jain, Catherine I. Vena, Mary Kay Kohles-Baker, Andre Rogatko, Zhiheng Xu, and Wayne B. Harris

Breast CancerBack

Comparison of Immunohistochemistry and Quantitative Reverse Transcription Polymerase Chain Reaction for Estrogen and Progesterone Receptor Status by Local and Central Laboratories Versus a Central Laboratory: ECOG 2197
Sunil S. Badve, Frederick L. Baehner, Robert P. Gray, Barrett H. Childs, Tara Maddala, Mei-Lan Liu, Steve C. Rowley, Steve A. Shak, Edith D. Perez, Lawrence J. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Lori J. Goldstein, and Joseph A. Sparano

Mammography Among Women Age 80 Years and Older With Breast Cancer
Brian D. Badgwell, Sharon H. Giordano, Zhigang Z. Duan, Shenying Fang, Isabelle Bedrosian, Henry M. Kuerer, S. Eva Singletary, Kelly K. Hunt, Gabriel N. Hortobagyi, and Gildy Babiera

Head and Neck CancerBack

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma
David M. Brizel, Barbara A. Murphy, David Ira Rosenthal, Kishan J. Pandya, Stefan Gluck, Herbert E. Brizel, Ruby F. Meredith, Dietmar Berger, Mon-Gy Chen, and William Mendenhall

Genitourinary CancerBack

Ten-Year Follow-Up of a Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer: RTOG 92-02
Eric M. Horwitz, Kyounghwa Bae, Gerald E. Hanks, Arthur Porter, David J. Grignon, Harmar D. Brereton, Varagur Venkatesan, Colleen A. Lawton, Seth A. Rosenthal, Howard M. Sandler, and William U. Shipley

Hematologic MalignanciesBack

Prolonged Survival in Patients With Myelodysplasia Responding to Immunosuppressive Therapy
Elaine M. Sloand, Colin Wu, Peter Greenberg, Neal Young, and John Barrett

Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma
Carole Soussain, Khe Hoang-Xuan, Luc Taillandier, Emmanuelle Fourme, Sylvain Choquet, Francis Witz, Olivier Casasnovas, Brigitte Dupriez, Bertrand Souleau, Anne-Laure Taksin, Christian Gisselbrecht, Arnaud Jaccard, Antonio Omuro, Marc Sanson, Maud Janvier, Brigitte Kolb, Jean-Marc Zini, and Veronique Leblond

Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Chronic Lymphocytic Leukemia Patients
Leslie Andritsos, Amy J. Johnson, Gerard Lozanski, William Blum, Cheryl Kefauver, Farrukh Awan, Lisa L. Smith, Rosa Lapalombella, Sarah E. May, Chelsey A. Raymond, Da-Sheng Wang, Robert D. Knight, Amy S. Ruppert, Amy Lehman, David Jarjoura, Ching-Shih Chen, and John C. Byrd

Gastrointestinal CancerBack

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
Stefan Heinrich, Bernhard C. Pestalozzi, Markus Schafer, Achim Weber, Peter Bauerfeind, Alexander Knuth, and Pierre-Alain Clavien

Adjuvant Chemotherapy for Stage III Colon Cancer: Do Physicians Agree About the Importance of Patient Age and Comorbidity?
Nancy L. Keating, Mary Beth Landrum, Carrie N. Klabunde, Robert H. Fletcher, Selwyn O. Rogers, William R. Doucette, Diana Tisnado, Steven Clauser, and Katherine L. Kahn

Supportive Care and Quality of LifeBack

Randomized Controlled Clinical Effectiveness Trial of Cognitive Behavior Therapy Versus Treatment As Usual for Persistent Insomnia in Patients With Cancer
Colin A. Espie, Leanne Fleming, Jim Cassidy, Leslie Samuel, Lynne M. Taylor, Craig A. White, Neil J. Douglas, Heather M. Engleman, Heidi-Louise Kelly, and James Paul

Assessing 2-Month Clinical Prognosis in Patients With Advanced Cancer
Anne-Claire Barbot, Pascale Mussault, Pierre Ingrand, and Jean-Marc Tourani

Pain Predicts Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer
Susan Halabi, Nicholas J. Vogelzang, Alice B. Kornblith, San-San Ou, Philip W. Kantoff, Nancy A. Dawson, and Eric J. Small

AIDS-Related CancerBack

HIV-Specific Differences in Outcome of Squamous Cell Carcinoma of the Anal Canal in Patients Receiving HAART
Christoph Oehler-Janne, Florence Huguet, Sawyna Provencher, Burkhardt Seifert, Laura Negrettti, Marc-Oliver Riener, Marta Bonet, Abdelkarim S. Allal, and I. Frank Ciernik

Gynecologic CancerBack

Histologic Results of Para-Aortic Lymphadenectomy In Patients Treated For Stage IB2/II Cervical Cancer With Negative [18] Fluorodeoxyglucose Positron Emission Tomography Scans
Mathias Boughanim, Sophie Leboulleux, Annie Rey, Chi Tuan Pham, Yaelle Zafrani, Pierre Duvillard, Jean Lumbroso, Christine Haie-Meder, Martin Schlumberger, and Philippe Morice

SPECIAL ARTICLEBack

American Society of Clinical Oncology Statement on Attributes of Exemplary Clinical Trial Sites
Robin Zon, Neal J. Meropol, Robert B. Catalano, and Richard L. Schilsky

BIOLOGY OF NEOPLASIABack

Basal-Like Breast Cancer: Characteristics and Clinical Significance
Emad A. Rakha, Jorge Sergio Reis-Filho, and Ian O. Ellis

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online